Feb 20, 2026Elevated Homocysteine Risk: Evidence for Vitamin B12 and TMG StrategiesHomocysteine is a useful risk-context biomarker. B-vitamin repletion and trimethylglycine can lower levels reliably, but clinical-outcome benefit depends on baseline risk and protocol quality.